|
CD 40 CD 40L与血栓性疾病研究进展 |
| |
CD 40CD 40 Ligand (CD 154) in patients with acute cerebral ischemia. Stroke. 2003,34:14121418.
[10] TOUSOULIS D，ANTONIADES C , NIKOLOPOULOU A，et al .Interaction between cytokines and sCD 40L in patients with stable and unstable coronary syndromes.Eur J Clin Invest. 2007 Aug;37(8):6238.
[11] YAN J C, ZHU J, GAO L, et al. The effect of elevated serum soluble CD 40 ligand on the prognostic value in patients with acute coronary syndromes. Clin Chim Acta, 2004,343: 155159.
[12] YAN J C, WU Z G, KONG X T, et al .Relation between upregulation of CD 40 system and complex stenosis morphology in patients with acute coronary syndrome. Acta Pharmacol Sin 2004 Feb;25 (2):251256.
[13] GARLICH CD,JOHN S , SCHMEBIER A ,et al. Upregulation of CD 40 ligand in patients with moderate hypercholesterolemia [ J ]. Circulation , 2001,104:23952400.
[14] CIPOLLONE F, FERRI C, DESIDERI T, et al. Preprocedural Level of Soluble CD 40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty. Circulation. 2003;108:27762782.
[15] ANDRE P ,PRASAD K S ,DENIS C V , et&nb上一页 [1] [2] [3] [4] [5] [6] [7] 下一页
上一个医学论文： C反应蛋白及其多态性与冠心病
下一个医学论文： 抗凝血酶治疗弥散性血管内凝血的研究进展
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文